|
HPS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.712300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.181400E-01 |
| Normal-vs-Stage2 |
1.142750E-01 |
| Normal-vs-Stage3 |
1.599630E-01 |
| Normal-vs-Stage4 |
6.906600E-01 |
| Stage1-vs-Stage2 |
1.731050E-01 |
| Stage1-vs-Stage3 |
1.941200E-01 |
| Stage1-vs-Stage4 |
8.176800E-01 |
| Stage2-vs-Stage3 |
8.593600E-01 |
| Stage2-vs-Stage4 |
4.434200E-01 |
| Stage3-vs-Stage4 |
5.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.180200E-01 |
| Normal-vs-AfricanAmerican |
3.132400E-01 |
| Normal-vs-Asian |
2.949400E-01 |
| Caucasian-vs-AfricanAmerican |
8.529600E-01 |
| Caucasian-vs-Asian |
3.266400E-01 |
| AfricanAmerican-vs-Asian |
4.080200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.622400E-01 |
| Normal-vs-Female |
3.457100E-03 |
| Male-vs-Female |
4.837600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.212800E-01 |
| Normal-vs-Extreme_Weight |
8.770400E-01 |
| Normal-vs-Obese |
1.027750E-01 |
| Normal-vs-Extreme_Obese |
7.960000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.358200E-01 |
| Normal_Weight-vs-Obese |
3.166000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.810200E-01 |
| Extreme_Weight-vs-Obese |
9.252100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.384600E-01 |
| Obese-vs-Extreme_Obese |
3.490600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.355800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.614200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.241400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.823800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.384100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.083000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.988300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.083800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.583960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.102000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.026400E-01 |
| Normal-VS-Type2 PRCC |
4.361000E-01 |
| Normal-VS-KIRP CIMP |
1.190070E-02 |
| Normal-VS-Unclassified PRCC |
1.466840E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.336800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.003950E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.485600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.562500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.633200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.656300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.592600E-01 |
| Normal-vs-N1 |
2.039900E-02 |
| Normal-vs-N2 |
8.390600E-01 |
| N0-vs-N1 |
2.012400E-01 |
| N0-vs-N2 |
7.596200E-01 |
| N1-vs-N2 |
2.678200E-01 |
|
|
